Rivulet Media Inc (fka RIVU)

[LaddyMan]

"KEY PLAYERS"- Just a matter of time. Why does it matter here? Because best information says BMSN owns a good chunk of REGEN!

Myelodysplastic syndrome pipeline market for 2016 available in new report

WhaTech Channel: Medical Market Research
Published: 23 June 2016
Submitted by RNR Market Research. WhaTech Agency
News from RnR Market Research

Complete Market Research Report on Myelodysplastic Syndrome Pipeline Development of the year 2016-Myelodysplastic Syndrome Pipeline Market Report 2016 - Key Players discussed in this reports are -

4SC AG ,Acceleron Pharma, Inc. ,Actinium Pharmaceuticals, Inc. ,Aeglea BioTherapeutics, Inc. ,Agios Pharmaceuticals, Inc.

,Altor BioScience Corporation ,Amgen Inc. ,Apogenix GmbH ,Arno Therapeutics, Inc.

,Arog Pharmaceuticals, Inc. ,Array BioPharma Inc. ,Astex Pharmaceuticals, Inc. ,Atara Biotherapeutics, Inc.

,Bellicum Pharmaceuticals, Inc.

,Bio-Path Holdings, Inc.
,BioLineRx, Ltd. ,BioLite, Inc. ,Boehringer Ingelheim GmbH ,Boryung Pharmaceutical Co., Ltd.

,Boston Biomedical, Inc. ,Bristol-Myers Squibb Company ,Cantex Pharmaceuticals, Inc. ,Celator Pharmaceuticals, Inc. ,Celgene Corporation ,Celldex Therapeutics, Inc.

,Cellerant Therapeutics, Inc. ,Celyad SA ,Constellation Pharmaceuticals, Inc. ,Cornerstone Pharmaceuticals, Inc.

,CrystalGenomics, Inc. ,CTI BioPharma Corp. ,Cyclacel Pharmaceuticals, Inc.

,Daiichi Sankyo Company, Limited ,DiNonA Inc. ,Eisai Co., Ltd. ,Eleos Inc. ,Eli Lilly and Company ,EpiZyme, Inc.

,F. Hoffmann-La Roche Ltd. ,FORMA Therapeutics, Inc. ,Fujifilm Corporation ,H3 Biomedicine Inc.

,IGF Oncology, LLC. ,ImmunoGen, Inc. ,Incyte Corporation ,Jiangsu Hansoh Pharmaceutical Co., Ltd.

,Johnson & Johnson ,Juno Therapeutics Inc. ,JW Pharmaceutical Corporation ,Kainos Medicine, Inc.

,KaloBios Pharmaceuticals, Inc. ,Karyopharm Therapeutics, Inc. ,Kiadis Pharma B.V.

,Kyowa Hakko Kirin Co., Ltd. ,La Jolla Pharmaceutical Company ,Les Laboratoires Servier SAS ,Lixte Biotechnology Holdings, Inc. ,MacroGenics, Inc. ,medac GmbH ,MedImmune, LLC ,MEI Pharma, Inc.

,Merck & Co., Inc. ,Merus B.V. ,Millennium Pharmaceuticals, Inc.

,Mirati Therapeutics Inc. ,Mirna Therapeutics, Inc. ,Nemucore Medical Innovations, Inc.

,Novartis AG ,Onconova Therapeutics, Inc. ,Opsona Therapeutics Limited ,OXiGENE, Inc.

,Pfizer Inc. ,Pharma Mar, S.A. ,Plexxikon Inc. ,Polyphor Ltd. ,Regen BioPharma, Inc.

,Rich Pharmaceuticals, Inc. ,Seattle Genetics, Inc. ,Stemline Therapeutics, Inc. ,Sumitomo Dainippon Pharma Co., Ltd.

,Sunesis Pharmaceuticals, Inc. ,Syndax Pharmaceuticals, Inc. ,Synta Pharmaceuticals Corp. ,Takeda Pharmaceutical Company Limited ,Targazyme, Inc.

,TetraLogic Pharmaceuticals ,Teva Pharmaceutical Industries Ltd. ,Threshold Pharmaceuticals, Inc.

,Toko Pharmaceutical Industries Co., Ltd. ,Tolero Pharmaceuticals, Inc. ,Tragara Pharmaceuticals, Inc.

,Trillium Therapeutics Inc.

Download complete report of 784 pages @ http://www.rnrmarketresearch.com/contacts/purchase?rname=617324

The report provides comprehensive information on the therapeutics under development for Myelodysplastic Syndrome, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

Additionally, the report provides an overview of key players involved in therapeutic development for Myelodysplastic Syndrome and features dormant and discontinued projects.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Scope

The report provides a snapshot of the global therapeutic landscape of Myelodysplastic Syndrome
The report reviews pipeline therapeutics for Myelodysplastic Syndrome by companies and universities/research institutes based on information derived from company and industry-specific sources
The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
The report reviews key players involved Myelodysplastic Syndrome therapeutics and enlists all their major and minor projects
The report assesses Myelodysplastic Syndrome therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
The report summarizes all the dormant and discontinued pipeline projects
The report reviews latest news related to pipeline therapeutics for Myelodysplastic Syndrome
Inquire more about this market research report @ http://www.rnrmarketresearch.com/contacts/inquire-before-buying?rname=617324

BMSN

https://www.whatech.com/market-research/medical/173999-myelodysplastic-syndrome-pipeline-market-for-2016-available-in-new-report